Pathophysiologic mechanisms, clinical features and treatment of idiopathic neutropenia

References

• Lakshman R, Finn A. Neutrophil disorders and their management. J. Clin. Pathol.54(1), 7–19 (2001).
   PubMed Web of Science ®Google Scholar
• Hoffbrand AV, Petit JE. The white cells. 1: Granulocytes, monocytes and their benign disorders. In: Essential Haematology. Hoffbrand AV, Petit JE (Eds). Blackwell Scientific Publications, Oxford, UK, 141–161 (1993).
   Google Scholar
• Lichtman MA. Classification and clinical manifestations of neutrophil disorders. In: Hematology. Williams WJ, Beutler E, Erslev AJ, Lichtman MA (Eds). McGraw-Hill Inc., NY, USA, 802–806 (1991).
   Google Scholar
• Dinauer MC, Coates TD. Disorders of phagocyte function and number. In: Hematology. Basic principles and practice. Hoffman R, Benz EJ, Shattil SJ et al. (Eds). Elsevier Inc., PA, USA, 787–855 (2005).
   Google Scholar
• Dale DC, Liles C. How many neutrophils are enough? Lancet351(9118), 1752–1753 (1998).
   PubMed Web of Science ®Google Scholar
• Palmblad J, Papadaki HA, Eliopoulos G. Acute and chronic neutropenias. What is new? J. Intern. Med.250(6), 476–491 (2001).
   PubMed Web of Science ®Google Scholar
• Dale DC. Neutropenia. In: Hematology. Williams WJ, Beutler E, Erslev AJ, Lichtman MA (Eds). McGraw-Hill Inc., NY, USA, 807–816 (1991).
   Google Scholar
• Papadaki HA. Chronic idiopathic neutropenia: clinical and pathophysiologic aspects. Presented at: 13th Congress of the European Hematology Association. Copenhagen, Denmark, 12–15 June 2008.
   Google Scholar
• Dale DC, Person RE, Bolyard AA et al. Mutations in the gene encoding neutrophil elastase in congenital and cyclic neutropenia. Blood96(7), 2317–2322 (2000).
   PubMed Web of Science ®Google Scholar
• Person RE, Li FQ, Duan Z et al. Mutations in proto-oncogene GFI1 cause human neutropenia and target ELA2. Nat. Genet.34(3), 308–312 (2003).
   PubMed Web of Science ®Google Scholar
• Klein C, Grudzien M, Appaswamy G et al. HAX1 deficiency causes autosomal recessive severe congenital neutropenia (Kostmann disease). Nat. Genet.39(1), 86–92 (2007).
   PubMed Web of Science ®Google Scholar
• Skokowa J, Cario G, Uenalan M et al. LEF-1 is crucial for neutrophil granulocytopoiesis and its expression is severely reduced in congenital neutropenia. Nat. Med.12(10), 1191–1197 (2006).
   PubMed Web of Science ®Google Scholar
• Shastri KA, Logue GL. Autoimmune neutropenia. Blood81(8), 1984–1995 (1993).
   PubMed Web of Science ®Google Scholar
• Capsoni F, Sarzi-Puttini P, Zanella A. Primary and secondary autoimmune neutropenia. Arthritis Res. Ther.7(5), 208–214 (2005).
   PubMed Web of Science ®Google Scholar
• Lamy T, Loughran TP Jr. Clinical features of large granular lymphocyte leukemia. Semin. Hematol.40(3), 185–195 (2003).
   PubMed Web of Science ®Google Scholar
• O’Malley DP. T-cell large granular leukemia and related proliferations. Am. J. Clin. Pathol.127(6), 850–859 (2007).
   PubMed Web of Science ®Google Scholar
• Bux J. Human neutrophil alloantigens. Vox Sang.94(4), 277–285 (2008).
   PubMed Web of Science ®Google Scholar
• Stroncek D. Granulocyte antigens and antibody detection. Vox Sang.87(Suppl. 1), 91–94 (2004).
   PubMedGoogle Scholar
• Lucas G, Rogers S, de Haas M, Porcelijn L, Bux J. Report on the Fourth International Granulocyte Immunology Workshop: progress toward quality assessment. Transfusion42(4), 462–468 (2002).
   PubMed Web of Science ®Google Scholar
• Verheugt FW, von dem Borne AE, Decary F, Engelfriet CP. The detection of granulocyte alloantibodies with an indirect immunofluorescence test. Br. J. Haematol.36(4), 533–544 (1977).
   PubMed Web of Science ®Google Scholar
• Bux J, Kober B, Kiefel V, Mueller-Eckhardt C. Analysis of granulocyte-reactive antibodies using an immunoassay based upon monoclonal-antibody-specific immobilization of granulocyte antigens. Transfus. Med.3(2), 157–162 (1993).
   PubMed Web of Science ®Google Scholar
• Bux J, Behrens G, Jaeger G, Welte K. Diagnosis and clinical course of autoimmune neutropenia in infancy: analysis of 240 cases. Blood91(1), 181–186 (1998).
   PubMed Web of Science ®Google Scholar
• Berliner N, Horwitz M, Loughran TP Jr. Congenital and acquired neutropenia. Hematology Am. Soc. Hematol. Educ. Program63–79 (2004).
   PubMedGoogle Scholar
• Bruin MC, von dem Borne AE, Tamminga RY, Kleijer M, Buddelmeijer L, de Haas M. Neutrophil antibody specificity in different types of childhood autoimmune neutropenia. Blood94(5), 1797–1802 (1999).
   PubMed Web of Science ®Google Scholar
• Bruin M, Dassen A, Pajkrt D, Buddelmeyer L, Kuijpers T, de Haas M. Primary autoimmune neutropenia in children: a study of neutrophil antibodies and clinical course. Vox Sang.88(1), 52–59 (2005).
   PubMed Web of Science ®Google Scholar
• Hartman KR, LaRussa VF, Rothwell SW, Atolagbe TO, Ward FT, Klipple G. Antibodies to myeloid precursor cells in autoimmune neutropenia. Blood84(2), 625–631 (1994).
   PubMed Web of Science ®Google Scholar
• Bux J, Chapman J. Report on the second international granulocyte serology workshop. Transfusion37(9), 977–983 (1997).
   PubMed Web of Science ®Google Scholar
• Lawrence JS, Craddock CG Jr, Campbell TN. Antineutrophilic serum, its use in studies of white blood cell dynamics. J. Lab. Clin. Med.69(1), 88–101 (1967).
   PubMed Web of Science ®Google Scholar
• Simpson DM, Ross R. Effects of heterologous antineutrophil serum in guinea pigs. Hematologic and ultrastructural observations. Am. J. Pathol.65(1), 79–102 (1971).
   PubMed Web of Science ®Google Scholar
• Boxer LA, Greenberg MS, Boxer GJ, Stossel TP. Autoimmune neutropenia. N. Engl. J. Med.293(15), 748–53 (1975).
   PubMed Web of Science ®Google Scholar
• Lalezari P, Jiang AF, Yegen L, Santorineou M. Chronic autoimmune neutropenia due to anti-NA2 antibody. N. Engl. J. Med.293(15), 744–747 (1975).
   PubMed Web of Science ®Google Scholar
• Maheshwari A, Christensen RD, Calhoun DA. Immune neutropenia in the neonate. Adv. Pediatr.49, 317–339 (2002).
   PubMedGoogle Scholar
• Harmon DC, Weitzman SA, Stossel TP. The severity of immune neutropenia correlates with the maturational specificity of antineutrophil antibodies. Br. J. Haematol.58(2), 209–215 (1984).
   PubMed Web of Science ®Google Scholar
• Shastri KA, O’Connor BM, Logue GL, Shimm DS, Rustagi PK. Light chain composition of serum granulocyte binding immunoglobulins. Am. J. Hematol.37(3), 167–172 (1991).
   PubMed Web of Science ®Google Scholar
• Bux J, Kissel K, Nowak K, Spengel U, Mueller-Eckhardt C. Autoimmune neutropenia: clinical and laboratory studies in 143 patients. Ann. Hematol.63(5), 249–252 (1991).
   PubMed Web of Science ®Google Scholar
• Papadaki HA, Michelakaki H, Bux J, Eliopoulos GD. Severe autoimmune neutropenia associated with bone marrow sea-blue histiocytosis. Br. J. Haematol.118(4), 931 (2002).
   PubMed Web of Science ®Google Scholar
• Logue GL, Shimm DS. Autoimmune granulocytopenia. Ann. Rev. Med.31, 191–200 (1980).
   PubMed Web of Science ®Google Scholar
• Kobayashi M, Nakamura K, Kawaguchi H et al. Significance of the detection of antineutrophil antibodies in children with chronic neutropenia. Blood99(9), 3468–3471 (2002).
   PubMed Web of Science ®Google Scholar
• Horwitz M, Benson KF, Person RE, Aprikyan AG, Dale DC. Mutations in ELA2, encoding neutrophil elastase, define a 21-day biological clock in cyclic haematopoiesis. Nat. Genet.23(4), 433–436 (1999).
   PubMed Web of Science ®Google Scholar
• Horwitz MS, Duan Z, Korkmaz B, Lee HH, Mealiffe ME, Salipante SJ. Neutrophil elastase in cyclic and severe congenital neutropenia. Blood109(5), 1817–1824 (2007).
   PubMed Web of Science ®Google Scholar
• Skokowa J, Germeshausen M, Zeidler C, Welte K. Severe congenital neutropenia: inheritance and pathophysiology. Curr. Opin. Hematol.14(1), 22–28 (2007).
   PubMed Web of Science ®Google Scholar
• Papadaki HA, Gibson FM, Rizzo S, Gordon-Smith EC, Marsh JC. Assessment of bone marrow stem cell reserve and function and stromal cell function in patients with autoimmune cytopenias. Blood96(9), 3272–3275 (2000).
   PubMed Web of Science ®Google Scholar
• Papadaki HA, Eliopoulos AG, Kosteas T et al. Impaired granulocytopoiesis in patients with chronic idiopathic neutropenia is associated with increased apoptosis of bone marrow myeloid progenitor cells. Blood101(7), 2591–2600 (2003).
   PubMed Web of Science ®Google Scholar
• Lyall EG, Lucas GF, Eden OB. Autoimmune neutropenia of infancy. J. Clin. Pathol.45(5), 431–434 (1992).
   PubMed Web of Science ®Google Scholar
• Smith MA, Smith JG. The use of granulocyte colony-stimulating factor for treatment of autoimmune neutropenia. Curr. Opin. Hematol.8(3), 165–169 (2001).
   PubMed Web of Science ®Google Scholar
• Panopoulos AD, Watowich SS. Granulocyte colony-stimulating factor: molecular mechanisms of action during steady state and ‘emergency’ hematopoiesis. Cytokine42(3), 277–288 (2008).
   PubMed Web of Science ®Google Scholar
• Kerst JM, de Haas M, van der Schoot CE et al. Recombinant granulocyte colony-stimulating factor administration to healthy volunteers: induction of immunophenotypically and functionally altered neutrophils via an effect on myeloid progenitor cells. Blood82(11), 3265–3272 (1993).
   PubMed Web of Science ®Google Scholar
• Kuijpers TW, de Haas M, de Groot CJ, von dem Borne AE, Weening RS. The use of rhG-CSF in chronic autoimmune neutropenia: reversal of autoimmune phenomena, a case history. Br. J. Haematol.94(3), 464–469 (1996).
   PubMed Web of Science ®Google Scholar
• Gaviria JM, van Burik JA, Dale DC, Root RK, Liles WC. Modulation of neutrophil-mediated activity against the pseudohyphal form of Candida albicans by granulocyte colony-stimulating factor (G-CSF) administered in vivo. J. Infect. Dis.179(5), 1301–1304 (1999).
   PubMed Web of Science ®Google Scholar
• Dale DC, Cottle TE, Fier CJ et al. Severe chronic neutropenia: treatment and follow-up of patients in the Severe Chronic Neutropenia International Registry. Am. J. Hematol.72(2), 82–93 (2003).
   PubMed Web of Science ®Google Scholar
• Bussel J, Lalezari P, Hilgartner M et al.Reversal of neutropenia with intravenous γ-globulin in autoimmune neutropenia of infancy. Blood62(2), 398–400 (1983).
   PubMed Web of Science ®Google Scholar
• Nugent DJ. IVIG in the treatment of children with acute and chronic idiopathic thrombocytopenic purpura and the autoimmune cytopenias. Clin. Rev. Allergy10(1–2), 59–71 (1992).
   PubMedGoogle Scholar
• Hilgartner MW, Bussel J. Use of intravenous γ globulin for the treatment of autoimmune neutropenia of childhood and autoimmune hemolytic anemia. Am. J. Med.83(4A), 25–29 (1987).
   PubMed Web of Science ®Google Scholar
• Ben-Chetrit E, Putterman C. Transient neutropenia induced by intravenous immune globulin. N. Engl. J. Med.326(4), 270–271 (1992).
   PubMedGoogle Scholar
• Lassiter HA, Bibb KW, Bertolone SJ, Patel CC, Stroncek DF. Neonatal immune neutropenia following the administration of intravenous immune globulin. Am. J. Pediatr. Hematol. Oncol.15(1), 120–123 (1993).
   PubMedGoogle Scholar
• Berkovitch M, Dolinski G, Tauber T, Aladjem M, Kaplinsky C. Neutropenia as a complication of intravenous immunoglobulin (IVIG) therapy in children with immune thrombocytopenic purpura: common and non-alarming. Int. J. Immunopharmacol.21(6), 11–15 (1999).
   Google Scholar
• Niebanck AE, Kwiatkowski JL, Raffini LJ. Neutropenia following IVIG therapy in pediatric patients with immune-mediated thrombocytopenia. J. Pediatr. Hematol. Oncol.27(3), 145–147 (2005).
   PubMed Web of Science ®Google Scholar
• Orbach H, Katz U, Sherer Y, Shoenfeld Y. Intravenous immunoglobulin: adverse effects and safe administration. Clin. Rev. Allergy Immunol.29(3), 173–184 (2005).
   PubMed Web of Science ®Google Scholar
• Darabi K, bdel-Wahab O, Dzik WH. Current usage of intravenous immune globulin and the rationale behind it: the Massachusetts General Hospital data and a review of the literature. Transfusion46(5), 741–753 (2006).
   PubMed Web of Science ®Google Scholar
• Anderson D, Ali K, Blanchette V et al. Guidelines on the use of intravenous immune globulin for hematologic conditions. Transfus. Med. Rev21(2 Suppl. 1), S9–S56 (2007).
   PubMed Web of Science ®Google Scholar
• Martino R, Sureda A, Ayats R, Muniz-Diaz E, Altes A, Brunet S. Successful treatment of chronic autoimmune neutropenia with cyclosporin A. Haematologica79(1), 66–69 (1994).
   PubMed Web of Science ®Google Scholar
• Kumakura S, Kobayashi S. Autoimmune neutropenia. Intern. Med.42(2), 133–134 (2003).
   PubMed Web of Science ®Google Scholar
• Ghnaya H, Bekov K, Jira M et al. Primary chronic autoimmune neutropenia successfully treated with sirolimus. Rev. Med. Interne DOI 10.1016/j.revmed.2008.02.005 (2008) (Epub ahead of print).
   Google Scholar
• Robak T. Monoclonal antibodies in the treatment of autoimmune cytopenias. Eur. J. Haematol.72(2), 79–88 (2004).
   PubMed Web of Science ®Google Scholar
• Reff ME, Carner K, Chambers KS et al. Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20. Blood83(2), 435–445 (1994).
   PubMed Web of Science ®Google Scholar
• Eisenberg R. Update on rituximab. Ann. Rheum. Dis.64(Suppl. 4), IV55–IV57 (2005).
   PubMedGoogle Scholar
• Berentsen S. Rituximab for the treatment of autoimmune cytopenias. Haematologica92(12), 1589–1596 (2007).
   PubMed Web of Science ®Google Scholar
• Dungarwalla M, Marsh JC, Tooze JA et al. Lack of clinical efficacy of rituximab in the treatment of autoimmune neutropenia and pure red cell aplasia: implications for their pathophysiology. Ann. Hematol.86(3), 191–197 (2007).
   PubMed Web of Science ®Google Scholar
• Faurschou M, Hasselbalch HC, Nielsen OJ. Sustained remission of platelet counts following monoclonal anti-CD20 antibody therapy in two cases of idiopathic autoimmune thrombocytopenia and neutropenia. Eur. J. Haematol.66(6), 408–411 (2001).
   PubMed Web of Science ®Google Scholar
• Reale LD, Besa EC. Rituximab in autoimmune pancytopenia: a case report and review of literature. Ann. Hematol.86(12), 913–916 (2007).
   PubMed Web of Science ®Google Scholar
• Provan D, Butler T, Evangelista ML, Amadori S, Newland AC, Stasi R. Activity and safety profile of low-dose rituximab for the treatment of autoimmune cytopenias in adults. Haematologica92(12), 1695–1698 (2007).
   PubMed Web of Science ®Google Scholar
• Ravandi F, O’Brien S. Alemtuzumab. Expert Rev. Anticancer Ther.5(1), 39–51 (2005).
   PubMed Web of Science ®Google Scholar
• Alinari L, Lapalombella R, Andritsos L, Baiocchi RA, Lin TS, Byrd JC. Alemtuzumab (Campath-1H) in the treatment of chronic lymphocytic leukemia. Oncogene26(25), 3644–3653 (2007).
   PubMed Web of Science ®Google Scholar
• Hale G, Xia MQ, Tighe HP, Dyer MJ, Waldmann H. The CAMPATH-1 antigen (CDw52). Tissue Antigens135(3), 118–127 (1990).
   Google Scholar
• Willis F, Marsh JC, Bevan DH et al. The effect of treatment with Campath-1H in patients with autoimmune cytopenias. Br. J. Haematol.114(4), 891–898 (2001).
   PubMed Web of Science ®Google Scholar
• Killick SB, Marsh JC, Hale G, Waldmann H, Kelly SJ, Gordon-Smith EC. Sustained remission of severe resistant autoimmune neutropenia with Campath-1H. Br. J. Haematol.97(2), 306–308 (1997)
   PubMed Web of Science ®Google Scholar
• Marsh JC, Gordon-Smith EC. CAMPATH-1H in the treatment of autoimmune cytopenias. Cytotherapy3(3), 189–195 (2001)
   PubMed Web of Science ®Google Scholar
• Papadaki HA, Palmblad J, Eliopoulos GD. Non-immune chronic idiopathic neutropenia of adult: an overview. Eur. J. Haematol.67(1), 35–44 (2001).
   PubMed Web of Science ®Google Scholar
• Palmblad J, Papadaki HA. Chronic idiopathic neutropenias and severe congenital neutropenia. Curr. Opin. Hematol.15(1), 8–14 (2008).
   PubMed Web of Science ®Google Scholar
• Dale DC, Bolyard AA, Schwinzer BG et al. The Severe Chronic Neutropenia International Registry: 10-year follow-up report. Support Cancer Ther.3(4), 220–231 (2006).
   PubMedGoogle Scholar
• Papadaki HA, Eliopoulos GD, Coulocheri SA, Spyropoulou M, Stavropoulos-Giokas C. Increased frequency of HLA-DRB1*1302 haplotype in patients with nonimmune chronic idiopathic neutropenia of adults. Blood97(2), 580–581 (2001).
   PubMed Web of Science ®Google Scholar
• Koene HR, de HM, Kleijer M, Huizinga TW, Roos D, von dem Borne AE. Clinical value of soluble IgG Fc receptor type III in plasma from patients with chronic idiopathic neutropenia. Blood91(10), 3962–3966 (1998).
   PubMed Web of Science ®Google Scholar
• Huizinga TW, de HM, Kleijer M, Nuijens JH, Roos D, von dem Borne AE. Soluble Fc γ receptor III in human plasma originates from release by neutrophils. J. Clin. Invest.86(2), 416–423 (1990).
   PubMed Web of Science ®Google Scholar
• Karlstrom R, Gustafson R, Palmblad J. Chronic mild neutropenia in adults: relation to IgG3 deficiency and infection susceptibility. J. Intern. Med.250(4), 342–347 (2001).
   PubMed Web of Science ®Google Scholar
• Papadaki HA, Palmblad J, Kapsimali V, Anagnou NP, Eliopoulos GD. Increased serum IgA and decreased IgG3 strongly correlate with increased serum TGF-β1 levels in patients with nonimmune chronic idiopathic neutropenia of adults. Eur. J. Haematol.65(4), 237–244 (2000).
   PubMed Web of Science ®Google Scholar
• Kamma JJ, Lygidakis NA, Nakou M. Subgingival microflora and treatment in prepubertal periodontitis associated with chronic idiopathic neutropenia. J. Clin. Periodontol.25(9), 759–765 (1998).
   PubMed Web of Science ®Google Scholar
• Zaromb A, Chamberlain D, Schoor R, Almas K, Blei F. Periodontitis as a manifestation of chronic benign neutropenia. J. Periodontol.77(11), 1921–1926 (2006).
   PubMed Web of Science ®Google Scholar
• Papadaki HA, Margioris AN, Miliaki M, Steriopoulos C, Valatas W, Eliopoulos GD. Chronic idiopathic neutropenia of adults is associated with decreased bone mineral density and alterations in bone turnover biochemical markers. Eur. J. Haematol.62(5), 311–316 (1999).
   PubMed Web of Science ®Google Scholar
• Papadaki HA, Tsatsanis C, Christoforidou A et al. Alendronate reduces serum TNFα and IL-1β, increases neutrophil counts, and improves bone mineral density and bone metabolism indices in patients with chronic idiopathic neutropenia (CIN)-associated osteopenia/osteoporosis. J. Bone Miner. Metab.22(6), 577–587 (2004).
   PubMed Web of Science ®Google Scholar
• Yakisan E, Schirg E, Zeidler C et al. High incidence of significant bone loss in patients with severe congenital neutropenia (Kostmann’s syndrome). J. Pediatr.131(4), 592–597 (1997).
   PubMed Web of Science ®Google Scholar
• Simon M, Lengfelder E, Reiter S, Hehlmann R. Osteoporosis in severe congenital neutropenia: inherent to the disease or a sequela of G-CSF treatment? Am. J. Hematol.52(2), 127 (1996).
   PubMed Web of Science ®Google Scholar
• Auner HW, Klintschar M, Crevenna R et al. Two case studies of chronic idiopathic neutropenia preceding acute myeloid leukaemia. Br. J. Haematol.105(2), 431–433 (1999).
   PubMed Web of Science ®Google Scholar
• Papadaki HA, Kosteas T, Gemetzi C, Alexandrakis M, Psyllaki M, Eliopoulos GD. Two patients with nonimmune chronic idiopathic neutropenia of adults developing acute myeloid leukemia with aberrant phenotype and complex karyotype but no mutations in granulocyte colony-stimulating factor receptor. Ann. Hematol.81(1), 50–54 (2002).
   PubMed Web of Science ®Google Scholar
• Papadaki HA, Kosteas T, Gemetzi C, Damianaki A, Anagnou NP, Eliopoulos GD. Acute myeloid/NK precursor cell leukemia with trisomy 4 and a novel point mutation in the extracellular domain of the G-CSF receptor in a patient with chronic idiopathic neutropenia. Ann. Hematol.83(6), 345–348 (2004).
   PubMed Web of Science ®Google Scholar
• Megalakaki A, Mitsouli C, Pontikoglou C et al. Chronic idiopathic neutropenia preceding polymyalgia rheumatica and acute myeloid leukemia. Ann. Hematol.83(12), 791–792 (2004).
   PubMed Web of Science ®Google Scholar
• Rosenberg PS, Alter BP, Bolyard AA et al. The incidence of leukemia and mortality from sepsis in patients with severe congenital neutropenia receiving long-term G-CSF therapy. Blood107(12), 4628–4635 (2006).
   PubMed Web of Science ®Google Scholar
• Donadieu J, Leblanc T, Bader MB et al. Analysis of risk factors for myelodysplasias, leukemias and death from infection among patients with congenital neutropenia. Experience of the French Severe Chronic Neutropenia Study Group. Haematologica90(1), 45–53 (2005).
   PubMed Web of Science ®Google Scholar
• Papadaki HA, Eliopoulos DG, Valatas V, Eliopoulos GD. Anemia of chronic disease is the more frequent type of anemia seen in patients with chronic idiopathic neutropenia of adults. Ann. Hematol.80(4), 195–200 (2001).
   PubMed Web of Science ®Google Scholar
• Pontikoglou C, Liapakis G, Pyrovolaki K et al. Evidence for downregulation of erythropoietin receptor in bone marrow erythroid cells of patients with chronic idiopathic neutropenia. Exp. Hematol.34(10), 1312–1322 (2006).
   PubMed Web of Science ®Google Scholar
• Psyllaki M, Damianaki A, Gemetzi C, Pyrovolaki K, Eliopoulos GD, Papadaki HA. Impaired megakaryopoiesis in patients with chronic idiopathic neutropenia is associated with increased transforming growth factor β1 production in the bone marrow. Br. J. Haematol.134(6), 624–631 (2006).
   PubMed Web of Science ®Google Scholar
• Papadaki HA, Eliopoulos GD. Selective loss of peripheral blood CD45RO+ T lymphocytes correlates with increased levels of serum cytokines and endothelial cell-derived soluble cell adhesion molecules in patients with chronic idiopathic neutropenia of adults. Ann. Hematol.77(4), 153–159 (1998).
   PubMed Web of Science ®Google Scholar
• Papadaki HA, Stamatopoulos K, Damianaki A et al. Activated T-lymphocytes with myelosuppressive properties in patients with chronic idiopathic neutropenia. Br. J. Haematol.128(6), 863–876 (2005).
   PubMed Web of Science ®Google Scholar
• Papadaki HA, Chatzivassili A, Stefanaki K, Koumaki V, Kanavaros P, Eliopoulos GD. Morphologically defined myeloid cell compartments, lymphocyte subpopulations, and histological findings of bone marrow in patients with nonimmune chronic idiopathic neutropenia of adults. Ann. Hematol.79(10), 563–570 (2000).
   PubMed Web of Science ®Google Scholar
• Kollner I, Sodeik B, Schreek S et al. Mutations in neutrophil elastase causing congenital neutropenia lead to cytoplasmic protein accumulation and induction of the unfolded protein response. Blood108(2), 493–500 (2006).
   PubMed Web of Science ®Google Scholar
• Papadaki HA, Horwitz M, Coulocheri SA, Person RA, Benson KF, Eliopoulos GD. Low levels of serum elastase are not associated with mutations in ELA-2 elastase encoding gene in chronic idiopathic neutropenia. Blood101(7), 2898–2899 (2003).
   PubMedGoogle Scholar
• Papadaki HA, Kosteas T, Gemetzi C, Christoforidou A, Anagnou NP, Eliopoulos GD. Low serum γ-glutamyltranspeptidase (GGT) in patients with chronic idiopathic neutropenia is not implicated in the pathophysiology of the disease. Haematologica88(11), ELT32 (2003)
   PubMedGoogle Scholar
• Papadaki HA, Eliopoulos GD. Enhanced neutrophil extravasation may be a contributing factor in the determination of neutropenia in patients with chronic idiopathic neutropenia of adults. Eur. J. Haematol.61(4), 272–277 (1998).
   PubMed Web of Science ®Google Scholar
• Papadaki HA, Giouremou K, Eliopoulos GD. Low frequency of myeloid progenitor cells in chronic idiopathic neutropenia of adults may be related to increased production of TGF-β1 by bone marrow stromal cells. Eur. J. Haematol.63(3), 154–162 (1999).
   PubMed Web of Science ®Google Scholar
• Koumaki V, Damianaki A, Ximeri M et al. Pro-inflammatory bone marrow milieu in patients with chronic idiopathic neutropenia is associated with impaired local production of interleukin-10. Br. J. Haematol.135(4), 570–573 (2006).
   PubMed Web of Science ®Google Scholar
• Papadaki HA, Pontikoglou C, Stavroulaki E et al. Soluble c-kit ligand production by bone marrow stromal cells is independent of the degree of neutropenia in patients with chronic idiopathic neutropenia. Ann. Hematol.85(3), 170–173 (2006).
   PubMed Web of Science ®Google Scholar
• Papadaki HA, Damianaki A, Pontikoglou C et al. Increased levels of soluble flt-3 ligand in serum and long-term bone marrow culture supernatants in patients with chronic idiopathic neutropenia. Br. J. Haematol.132(5), 637–639 (2006).
   PubMed Web of Science ®Google Scholar
• Spanoudakis M, Koutala H, Gemetzi C, Eliopoulos GD, Papadaki HA. T-cell receptor Vb repertoire analysis in chronic idiopathic neutropenia: evidence for presence of prominent T-cell clones with pathogenetic significance. Hematologica/Haematology J.91(Suppl. 1), 178 (2006).
   Google Scholar
• Wlodarski MW, Nearman Z, Jiang Y, Lichtin A, Maciejewski JP. Clonal predominance of CD8(+) T cells in patients with unexplained neutropenia. Exp. Hematol.36(3), 293–300 (2008).
   PubMed Web of Science ®Google Scholar
• Davidson A, Diamond B. Autoimmune diseases. N. Engl. J. Med.345(5), 340–350 (2001).
   PubMed Web of Science ®Google Scholar
• Risitano AM, Maciejewski JP, Selleri C, Rotoli B. Function and malfunction of hematopoietic stem cells in primary bone marrow failure syndromes. Curr. Stem Cell Res. Ther.2(1), 39–52 (2007).
   PubMedGoogle Scholar
• Young NS, Maciejewski JP, Sloand E et al. The relationship of aplastic anemia and PNH. Int. J. Hematol.76(Suppl. 2), 168–172 (2002).
   PubMed Web of Science ®Google Scholar
• O’Keefe CL, Plasilova M, Wlodarski M et al. Molecular analysis of TCR clonotypes in LGL: a clonal model for polyclonal responses. J. Immunol.172(3), 1960–1969 (2004).
   PubMed Web of Science ®Google Scholar
• Freedman MH, Alter BP. Risk of myelodysplastic syndrome and acute myeloid leukemia in congenital neutropenias. Semin. Hematol.39(2), 128–133 (2002).
   PubMed Web of Science ®Google Scholar
• Kaczmarski RS, Pozniak A, Lakhani A, Harvey E, Mufti GJ. A pilot study of low-dose recombinant human granulocyte-macrophage colony-stimulating factor in chronic neutropenia. Br. J. Haematol.84(2), 338–340 (1993).
   PubMed Web of Science ®Google Scholar
• Yetgin S, Ozbek N. High-dose methylprednisolone-induced dramatic maturation of granulocytes in idiopathic chronic neutropenia. Turk. J. Pediatr.39(2), 259–263 (1997).
   PubMed Web of Science ®Google Scholar
• Cottle TE, Fier CJ, Donadieu J, Kinsey SE. Risk and benefit of treatment of severe chronic neutropenia with granulocyte colony-stimulating factor. Semin. Hematol.39(2), 134–140 (2002).
   PubMed Web of Science ®Google Scholar
• Chung BH, Chan GC, Lee TL et al. Chronic benign neutropenia among Chinese children. Hong Kong Med. J.10(4), 231–236 (2004).
   PubMedGoogle Scholar
• Juul SE, Christensen RD. Effect of recombinant granulocyte colony-stimulating factor on blood neutrophil concentrations among patients with “idiopathic neonatal neutropenia”: a randomized, placebo-controlled trial. J. Perinatol.23(6), 493–497 (2003).
   PubMedGoogle Scholar
• Yilmaz D, Ritchey AK. Severe neutropenia in children: a single institutional experience. J. Pediatr. Hematol. Oncol.29(8), 513–518 (2007).
   PubMed Web of Science ®Google Scholar
• Stetler-Stevenson M, Arthur DC, Jabbour N et al. Diagnostic utility of flow cytometric immunophenotyping in myelodysplastic syndrome. Blood98(4), 979–987 (2001).
   PubMed Web of Science ®Google Scholar
• Wells DA, Benesch M, Loken MR et al. Myeloid and monocytic dyspoiesis as determined by flow cytometric scoring in myelodysplastic syndrome correlates with the IPSS and with outcome after hematopoietic stem cell transplantation. Blood102(1), 394–403 (2003).
   PubMed Web of Science ®Google Scholar
• Papadaki HA, Kritikos HD, Gemetzi C et al. Bone marrow progenitor cell reserve and function and stromal cell function are defective in rheumatoid arthritis: evidence for a tumor necrosis factor α-mediated effect. Blood99(5), 1610–1619 (2002).
   PubMed Web of Science ®Google Scholar
• Papadaki HA, Kritikos HD, Valatas V, Boumpas DT, Eliopoulos GD. Anemia of chronic disease in rheumatoid arthritis is associated with increased apoptosis of bone marrow erythroid cells: improvement following anti-tumor necrosis factor-α antibody therapy. Blood100(2), 474–482 (2002).
   PubMed Web of Science ®Google Scholar